[HTML][HTML] Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo …

M Haude, A Wlodarczak, RJ van der Schaaf… - …, 2023 - thelancet.com
Background A third-generation coronary drug-eluting resorbable magnesium scaffold
(DREAMS 3G) was developed to enhance the performance of previous scaffold generations …

Long-term outcomes following bioresorbable vascular scaffolds

K Miyashita, K Ninomiya, A Tobe… - Expert Review of …, 2024 - Taylor & Francis
Introduction The higher scaffold thrombosis rates observed with the first-generation
bioresorbable scaffolds (BRSs) compared to conventional drug-eluting stents were likely …

[HTML][HTML] Research on the Current Application Status of Magnesium Metal Stents in Human Luminal Cavities

X Chen, Y Xia, S Shen, C Wang, R Zan, H Yu… - Journal of Functional …, 2023 - mdpi.com
The human body comprises various tubular structures that have essential functions in
different bodily systems. These structures are responsible for transporting food, liquids …

Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds–magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort

A Włodarczak, P Rola, M Barycki… - … & Vascular Disease …, 2023 - journals.sagepub.com
Background Diabetes type 2 is one of the strongest risk factors affecting coronary artery
disease (CAD) and is also a marker of poor short and long-term prognosis in subjects with …

Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes …

A Włodarczak, P Rola, S Włodarczak… - … Cardiology/Postępy w …, 2024 - termedia.pl
Aim: We designed this study to evaluate the mid-term safety and efficiency of the Magmaris
BRS in comparison to the leading new-generation ultrathin DES Ultimaster in the ACS …

The Short‐Term and One‐Year Clinical Outcomes in Patients with Optical Coherence Tomography‐Guided Magmaris Implantation: A Real‐World Clinical Practice

MJ Chuang, WC Huang, YY Chen… - Journal of Interventional …, 2024 - Wiley Online Library
Aims. We aimed to evaluate the acute performance and short‐and long‐term outcomes of
optical coherence tomography (OCT)‐guided Magmaris deployment. Methods. This was a …

[HTML][HTML] Global trends in the research of biodegradable biomedical magnesium-based materials: a bibliometric analysis

Y Zhu, Y Liu, L Wu, Q Yang - Frontiers in Materials, 2023 - frontiersin.org
Background: In recent years, there has been a notable surge in the interest surrounding
biodegradable materials, particularly in the context of biomedical applications. This has led …

[HTML][HTML] Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large …

A Włodarczak, P Rola, S Włodarczak… - Journal of Personalized …, 2024 - mdpi.com
Background: The acute coronary syndrome (ACS) continues to be a fundamental indication
for revascularization by percutaneous coronary intervention (PCI). Drug-eluting stent (DES) …

Optimal Pre-dilatation Treatment before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis. The OPTIMIS trial

KN Hansen, J Trøan, A Maehara, M Noori, M Hougaard… - medRxiv, 2024 - medrxiv.org
Introduction: Bioresorbable scaffolds (BRS) have been developed to overcome limitations
related to late stent failures of drug-eluting-stents, but previous studies have observed lumen …

[PDF][PDF] ALIMBAEV KAISAR SERIKOVICH1, ARIPOV MARAT ASANOVICH1, GONCHAROV ALEXEY

KBB YURYEVICH, AB ALKENOVNA - pharmkaz.kz
stent implantation is effective method of overcome critical vessel narrowing and restore
normal flowing of blood in affected ones in patients with сoronary artery disease. Using …